Q2 2019 Holdings
Filed 2019-08-07 | 44 holdings | $168.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC(ADAPY) | ADR | 00653A107 | $63.6M | 15,832,611 | 37.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $41.3M | 15,335,047 | 24.4% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $34.0M | 5,172,683 | 20.2% |
| Bloom Energy Corp(BE) | COM CL A | 093712107 | $16.4M | 1,333,333 | 9.7% |
| Champions Oncology Inc(CSBR) | COM NEW | 15870P307 | $12.2M | 1,562,500 | 7.2% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $184.6K | 6,138,797 | 0.1% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $108.3K | 9,089,041 | 0.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $108.1K | 4,912,306 | 0.1% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $98.5K | 2,090,678 | 0.1% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $98.3K | 2,268,188 | 0.1% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $87.2K | 6,643,704 | 0.1% |
| Senseonics Holdings Inc(SENS1GBP) | COM | 81727U105 | $63.0K | 30,888,266 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $54.9K | 4,377,518 | 0.0% |
| Obseva SA | COM | H5861P103 | $51.9K | 4,586,563 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $48.2K | 11,894,267 | 0.0% |
| Marker Therapeutics Inc | COM | 57055L107 | $39.6K | 5,000,000 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $38.5K | 4,229,410 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $33.5K | 3,506,649 | 0.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $33.2K | 4,429,804 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $28.3K | 7,225,676 | 0.0% |
| Millendo Therapeutics Inc | COM | 60040X103 | $20.4K | 1,766,779 | 0.0% |
| Liquidia Technologies Inc(LQDA) | COM | 53635D202 | $19.9K | 2,486,062 | 0.0% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | COM | 053588109 | $16.9K | 25,243,865 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $15.0K | 2,382,286 | 0.0% |
| Affimed NV | COM | N01045108 | $14.7K | 5,138,888 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $14.3K | 5,720,572 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $13.0K | 4,141,308 | 0.0% |
| Dasan Zhone Solutions Inc(DZSIEUR) | COM NEW | 23305L206 | $12.4K | 956,255 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $9.3K | 3,315,149 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $8.5K | 3,243,150 | 0.0% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $6.2K | 1,219,674 | 0.0% |
| Proteostasis Therapeutics Inc | COM | 74373B109 | $5.4K | 5,556,778 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $5.0K | 333,333 | 0.0% |
| Erytech Pharma SA | ADR | 29604W108 | $4.5K | 625,000 | 0.0% |
| Trevena Inc | COM | 89532E109 | $3.9K | 3,811,691 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $3.2K | 3,750,000 | 0.0% |
| Regulus Therapeutics Inc | COM NEW | 75915K200 | $2.6K | 2,052,455 | 0.0% |
| Tracon Pharmaceuticals Inc | COM | 89237H100 | $2.4K | 3,467,181 | 0.0% |
| Endologix Inc | COM | 29266S106 | $1.8K | 249,021 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.8K | 182,754 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $943 | 1,298,274 | 0.0% |
| Akari Therapeutics PLC | ADR | 00972G108 | $913 | 452,167 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $691 | 2,100,000 | 0.0% |
| Achaogen Inc | COM | 004449104 | $99 | 5,215,128 | 0.0% |